Document Detail


Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer.
MedLine Citation:
PMID:  18555224     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate vaginal compared to intramuscular (IM) progesterone supplementation for luteal phase support after in vitro fertilization and embryo transfer (IVF-ET).
DESIGN: Retrospective matched-samples comparative study.
SETTING: Private infertility center.
PATIENTS(S): Two hundred forty patients undergoing IVF-ET.
INTERVENTION(S): Patients received either vaginal progesterone supplementation in the form of Endometrin 100 mg twice a day (n = 12), Endometrin 100 mg three times a day (n = 11), or Crinone 8% gel 90 mg every day (n = 17), or 50 mg every day IM progesterone in oil (n = 200).
MAIN OUTCOME MEASURE(S): Clinical intrauterine pregnancy rates, pregnancy loss, and live birth rates.
RESULT(S): Among patients using vaginal progesterone, there were no statistically significant differences in patient characteristics and clinical outcomes, regardless of the type of vaginal progesterone used. There were no differences in outcomes between the vaginal and IM progesterone treatment groups. There were 20 pregnancies (50.0%) among patients treated with vaginal progesterone and 103 pregnancies (51.5%) among matched IM progesterone patients. The live birth rates were 47% in the IM versus 47.5% in the vaginal progesterone groups. There were no statistically significant differences in miscarriage rates between groups.
CONCLUSION(S): There are no significant differences in treatment outcomes between vaginal and IM progesterone supplementation, yielding similar clinical pregnancy, miscarriage, and live birth rates.
Authors:
Naveed Khan; Kevin S Richter; Tasha L Newsome; Emily J Blake; Vladimir I Yankov
Related Documents :
21354074 - Successful retrieval of an intrauterine device with "missing strings" using a manual va...
21480484 - Wisconsin stillbirth services program: a multifocal approach to stillbirth analysis.
2498134 - Artificially induced menstrual cycle with natural estradiol and progesterone.
21449834 - The association between stillbirth and fetal gender.
3842214 - Contraceptive efficacy of bioabsorbable pellets of norethindrone (net) as subcutaneous ...
3841264 - Terminal deoxynucleotidyl transferase activity in thymocytes of kittens.
Publication Detail:
Type:  Journal Article     Date:  2008-06-13
Journal Detail:
Title:  Fertility and sterility     Volume:  91     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-01     Completed Date:  2009-07-08     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2445-50     Citation Subset:  IM    
Affiliation:
Shady Grove Fertility Reproductive Science Center, Rockville, Maryland 20850, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous / epidemiology
Birth Rate
Embryo Transfer / methods*
Female
Fertilization in Vitro / methods*
Humans
Infant, Newborn
Injections
Injections, Intramuscular
Pregnancy
Pregnancy Outcome
Progesterone / administration & dosage,  therapeutic use*
Vagina
Chemical
Reg. No./Substance:
57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correlation of antim??llerian hormone and baseline follicle-stimulating hormone levels.
Next Document:  Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis.